131233-71-1

Upstream product

• 131147-11-0 (3aR,4S,5S,6R,7S,7aS)-4-Allyloxy-5,6,7-tris-benzyloxy-2,2-dimethyl-hexahydro-benzo[1,3]dioxole 
• 164904-89-6 6-O-allyl-3,4,5-tri-O-benzyl-1,2-O-cyclohexylidene-L-myo-inositol 
• 100-39-0 benzyl bromide 
• 23393-20-6 D-1-O-benzyl-2,3:5,6-di-O-cyclohexylidene-myo-inositol 
• 154459-83-3 1L-6-O-allyl-3-O-benzyl-1,2-O-cyclohexylidene-myo-inositol 
• 154459-93-5 1L-6-O-allyl-3-O-benzyl-1,2:4,5-di-O-cyclohexylidene-myo-inositol 
• 38643-30-0 (±)-1,2:5,6-di-O-isopropylidene-myo-inositol 
• 131147-11-0 (±)-2,3-O-isopropylidene-1,5,6-tri-O-benzyl-4-O-allyl-myo-inositol 
• 87-89-8 D-myo-inositol 
• 131146-87-7 (±)-4-O-allyl-1-O-benzyl-2,3;5,6-di-O-isopropylidene-myo-inositol 
• 120679-73-4 (+/-)-3,4-di-O-benzyl-1,2:5,6-di-O-isopropylidene-myo-inositol 
• 131146-90-2 (+/-)-3-O-benzyl-1,2-O-isopropylidene-6-O-p-methoxybenzyl-myo-inositol 
• 131147-03-0 (+/-)-3,4-di-O-benzyl-1,2-O-isopropylidene-myo-inositol 
• 58706-24-4 (±)-3-O-benzyl-1,2:4,5-di-O-isopropylidene-myo-inositol 

Downstream Products

• 131233-72-2 1,6-di-O-allyl-3,4,5-tri-O-benzyl-L-myo-inositol 
• 154459-84-4 1L-6-O-allyl-3,4,5-tri-O-benzyl-1-O-(4-methoxybenzoyl)-myo-inositol 
• 131147-16-5 C₄₀H₄₄O₆ 
• 131233-74-4 2-O,3-O,4-O,5-O-tetrabenzyl-L-myo-inositol 
• 131147-14-3 1D-1,3,5,6-tetra-O-benzyl-myo-inositol 
• 1323371-48-7 (3,4-di-O-benzyl-6-O-acetyl-2-azido-2-deoxy-α-D-glucopyranosyl)-(1->6)-1-O-p-methoxybenzyl-2,3,4,5-tetra-O-benzyl-L-myo-inositol 
• 131147-17-6 C₅₄H₆₀O₁₂ 
• 131147-17-6 C₅₄H₆₀O₁₂ 
• 131146-82-2 C₅₄H₆₀O₁₂ 
• 131146-82-2 C₅₄H₆₀O₁₂ 
• 6195-66-0 (+/-)-1,2,5,6-tetra-O-benzyl-myo-inositol 
• 131147-14-3 (+/-)-1,3,4,5-tetra-O-benzyl-myo-inositol 
• 1323371-30-7 6-O-allyl-3,4,5-tri-O-benzyl-1,2-O-{(+)-1,7,7-trimethyl[2,2,1]bicyclohepta-6-ylidene}-D-myo-inositol 
• 1323371-32-9 6-O-allyl-3,4,5-tri-O-benzyl-1,2-O-{(+)-1,1,7-trimethylbicyclo[2.2.1]hept-6-ylidene}-L-myo-inositol 

Relevant academic research and scientific papers

Synthesis of new fluorescently labeled glycosylphosphatidylinositol (GPI) anchors

The borondipyrromethene (BODIPY) labeled new glycosylphosphatidylinositol (GPI) molecules were synthesized as cellular probes to study the chemical basis of microdomain organization of GPI-anchored proteins and cholesterol in plasma membrane. The synthesi

Synthesis of phosphatidylinositol mannosides (PIMs)

Two strategies towards the synthesis of phosphatidylinositol mannosides (PIMs) were elaborated which permit selective access to the O-1-, O-2-, and the O-6 position of the myo-inositol residue. Starting materials are 1,2:5,6- and 1,2:4,5-di-O-cyclohexylid

Parasite Glucoconjugates. Part 1. The Synthesis of Some Early and Related Intermediates in the Biosynthetic Pathway of Glycosyl-phosphatidylinositol Membrane Anchors

The enantio-pure 1D- and 1L-myo-inositol derivative 3D and 3L have been used to prepare sodium 1D-6-O-(2-amino-2-deoxy-α-D-glucopyranosyl)-myo-inositol sn-2,3-dipalmitoyloxypropyl phosphate 21 and a related 1,6-disubstituted 1L-myo-inositol 28, respective

Synthesis of racemic 3-methylphosphonate analogues of myo-inositol 3,4-bis- and 1,3,4-trisphosphate

The partially benzyl protected myo-inositol derivatives 11a and 11b, the C-4 and C-1,4 hydroxyl function(s) of which are protected with temporary trans-prop-1-enyl protecting group(s), were readily converted into the respective title compounds 18a and 18b by sequential methylphosphonylation, mild cleavage of the trans-prop-1-enyl group(s), phosphorylation and removal of all permanent benzyl protecting groups.

The synthesis and resolution of (+/-)-1,5,6-tri-O-benzyl-myo-inositol

Racemic 1,5,6-O-benzyl-myo-inositol was prepared by five routes and converted into 1,5,6-tri-O-benzyl-2,3-O-isopropylidene-myo-inositol, the camphanates of which were readily separated by chromatography.The absolute configurations of the chiral derivative